Long-term outcomes in the second-line treatment of chronic myeloid leukemia: A review of tyrosine kinase inhibitors

Elias Jabbour, Jorge Cortes, Hagop Kantarjian

Research output: Contribution to journalReview articlepeer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term outcomes in the second-line treatment of chronic myeloid leukemia: A review of tyrosine kinase inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences